Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.9% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

7(100.0%)

7Total

N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07751562Not ApplicableNot Yet Recruiting

KPAP vs AirSense 11 With EPR

Role: lead

NCT07530523Not ApplicableNot Yet Recruiting

KPAP vs EPR for Efficacy

Role: lead

NCT06413134Not ApplicableNot Yet Recruiting

KPAP Adherence Crossover Study

Role: lead

NCT07530510Not ApplicableNot Yet Recruiting

KPAP vs EPR for Comfort

Role: lead

NCT06264128Not ApplicableCompleted

TPAP for Comfort in OSA

Role: lead

NCT06238362Not ApplicableCompleted

TheraPAP Equivalence Crossover Study

Role: lead

NCT06407999Not ApplicableWithdrawn

Pressure Relief Algorithm Eval

Role: lead

All 7 trials loaded